Abeona Therapeutics(ABEO)
5.51 0.32 6.1657%
| 今开：5.2 | 昨收：5.19 |
| 最高：5.6 | 最低：5.2 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：2.25704444E8 |
Abeona Therapeutics的热门讨论
chuminhua04-23 11:46
4/22，Abeona Therapeutics $Abeona Therapeutics(ABEO)$ 表示，其针对隐性营养不良性大疱性表皮松解症 (DEB) 患者的自体基因校正细胞疗法 prademagene zamikeracel (pz-cel) 收到了 FDA 的完整回复信 (CRL)。 该公司股价周一盘后交易中暴跌 51%。
FDA 表示，Abeona 必须满足额外的CMC 要求才...查看全文
持股变动声明
Abeona Therapeutics(ABEO)06-21 04:35
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-024527 Size: 5 KB 网页链接查看全文
持股变动声明
Abeona Therapeutics(ABEO)06-08 04:35
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-023117 Size: 5 KB 网页链接查看全文
持股变动声明
Abeona Therapeutics(ABEO)06-08 04:35
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-023122 Size: 5 KB 网页链接查看全文
增发股票注册声明
Abeona Therapeutics(ABEO)06-12 19:05
$Abeona Therapeutics(ABEO)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001493152-24-023541 Act: 33 Size: 1 MB 网页链接查看全文
增发股票注册声明「修订」
Abeona Therapeutics(ABEO)06-18 05:25
$Abeona Therapeutics(ABEO)$ S-3/A [Amend] Registration statement under Securities Act of 1933 Accession Number: 0001493152-24-024171 Act: 33 Size: 646 KB 网页链接查看全文
当期报告
Abeona Therapeutics(ABEO)07-10 04:35
$Abeona Therapeutics(ABEO)$ 8-K Current report, items 5.03 and 9.01 Accession Number: 0001493152-24-026640 Act: 34 Size: 362 KB 网页链接查看全文
持股变动声明
Abeona Therapeutics(ABEO)07-10 04:45
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026648 Size: 5 KB 网页链接查看全文
持股变动声明
Abeona Therapeutics(ABEO)07-10 04:45
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026641 Size: 4 KB 网页链接查看全文
当期报告
Abeona Therapeutics(ABEO)05-04 05:25
$Abeona Therapeutics(ABEO)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001493152-24-017768 Act: 34 Size: 1 MB 网页链接查看全文
Abeona Therapeutics的最新讨论
神鹰20072020-11-12 08:41
$Abeona Therapeutics(ABEO)$ holding nice from 1.05 bottom play [跪了][跪了][跪了][跪了]查看全文
Replix锐璞美股2020-11-11 22:40
$Abeona Therapeutics(ABEO)$ 接着按剧本走，![[大笑]](http://js.xueqiu.com/ugc/images/face/emoji_02_laughing.png?v=1 "[大笑]"){kind=small}
![[赚大了]](http://js.xueqiu.com/ugc/images/face/emoji_06_money.png?v=1 "[赚大了]"){kind=small}
，反反复复
$Five Prime(FPRX)$ $BioNTech(BNTX)$查看全文
![[俏皮]](http://js.xueqiu.com/ugc/images/face/emoji_04_cool.png?v=1 "[俏皮]"){kind=small}
Replix锐璞美股2020-10-09 08:45
$Abeona Therapeutics(ABEO)$ $Iovance(IOVA)$ 抄底收益不错！$Cardiff Oncology(CRDF)$ 表现很不错！![[献花花]](http://js.xueqiu.com/ugc/images/face/emoji_38_flower.png?v=1 "[献花花]"){kind=small}
查看全文
战马恋歌2020-09-30 23:10
$Abeona Therapeutics(ABEO)$ 管理层屎💩一般的烂，一手好牌打的稀巴烂，10几块的时候买过，现在居然要迈向毛票了，关键还不是因为管线和数据的问题…纯管理的无能这就很悲哀了…干脆直接跌到5毛好了![[吐血]](http://js.xueqiu.com/ugc/images/face/emoji_23_blood.png?v=1 "[吐血]"){kind=small}
也好能接点看能不能吃个苍蝇肉![[抠鼻]](http://js.xueqiu.com/ugc/images/face/emoji_24_nose.png?v=1 "[抠鼻]"){kind=small}
查看全文
![[跪]](http://js.xueqiu.com/ugc/images/face/emoji_63_gui.png?v=1 "[跪]"){kind=small}
chuminhua2020-08-18 15:40
8/17，Abeona Therapeutics Inc.$Abeona Therapeutics(ABEO)$ 和基因疗法公司Taysha Gene Therapies宣布就ABO-202达成购买和授权协议。ABO-202是针对CLN1疾病（也称为本杰明·巴顿病）的腺相关病毒（AAV）基因疗法。协议授予Taysha全球范围内的独家权益，该药物是由北卡罗来纳大学教堂山分校（UNC...查看全文
Replix锐璞美股2020-05-31 22:48
除了基因编辑三剑客CRSP/EDIT/NTLA，基因治疗我们还覆盖了$uniQure(QURE)$ 网页链接
Regenxbio(RGNX)$ 网页链接
Abeona Therapeutics(ABEO)${Abeona Therapeutics(ABEO)$} 网页链接查看全文
Replix锐璞美股2020-05-21 15:45
$Abeona Therapeutics(ABEO)$ 财报季，我们更新了ABEO的估值模型，请查看：网页链接。
$Altimmune(ALT)$ $Beyond Meat(BYND)$
@淘沙见金 @飞冲天 @书呆老李 @Efficacious @Replix锐璞-Yang @美股医药Z博士 @药师老庙 @跑江糊查看全文
Abeona Therapeutics的新闻
Abeona Therapeutics(ABEO.US)基因校正表皮获FDA优先审评资格
智通财经APP获悉，11月27日，Abeona Therapeutics(ABEO.US)宣布，美国FDA已接受其在研疗法pz-cel(prademagene zamikeracel，EB-101)的生物制品许可申请(BLA)，并授予优先审评资格，该疗法是一款自体、COL7A1基因校正表皮片，用于隐性... 网页链接
Abeona Therapeutics的公告
持股变动声明
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026645 Size: 4 KB 网页链接
持股变动声明
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026641 Size: 4 KB 网页链接
持股变动声明
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026644 Size: 4 KB 网页链接
持股变动声明
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026642 Size: 5 KB 网页链接
持股变动声明
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026643 Size: 4 KB 网页链接
持股变动声明
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026646 Size: 5 KB 网页链接
持股变动声明
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026647 Size: 5 KB 网页链接
持股变动声明
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026649 Size: 5 KB 网页链接
持股变动声明
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026648 Size: 5 KB 网页链接
当期报告
$Abeona Therapeutics(ABEO)$ 8-K Current report, items 5.03 and 9.01 Accession Number: 0001493152-24-026640 Act: 34 Size: 362 KB 网页链接